Home LiteratureArticle Details
PMID: 12506200 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB

Abstract

Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of particular relevance for elucidating the role of Abeta in AD is new evidence that oligomeric forms of Abeta are potent neurotoxins that play a major role in neurodegeneration and the strong association of the 42-residue form of Abeta, Abeta42, with the disease. Detailed knowledge of the structure and assembly dynamics of Abeta thus is important for the development of properly targeted AD therapeutics. Recently, we have shown that Abeta oligomers can be cross-linked efficiently, and their relative abundances quantified, by using the technique of photo-induced cross-linking of unmodified proteins (PICUP). Here, PICUP, size-exclusion chromatography, dynamic light scattering, circular dichroism spectroscopy, and electron microscopy have been combined to elucidate fundamental features of the early assembly of Abeta40 and Abeta42. Carefully prepared aggregate-free Abeta40 existed as monomers, dimers, trimers, and tetramers, in rapid equilibrium. In contrast, Abeta42 preferentially formed pentamerhexamer units (paranuclei) that assembled further to form beaded superstructures similar to early protofibrils. Addition of Ile-41 to Abeta40 was sufficient to induce formation of paranuclei, but the presence of Ala-42 was required for their further association. These data demonstrate that Abeta42 assembly involves formation of several distinct transient structures that gradually rearrange into protofibrils. The strong etiologic association of Abeta42 with AD may thus be a result of assemblies formed at the earliest stages of peptide oligomerization.

MeSH Terms
Alzheimer Disease/pathology Amyloid beta-Peptides/biosynthesis,isolation & purification,metabolism Humans Models, Neurological Molecular Weight Peptide Fragments/isolation & purification,metabolism
Chemicals
Amyloid beta-Peptides Peptide Fragments amyloid beta-protein (1-40) amyloid beta-protein (1-42)
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bitan Gal
Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Kirkitadze Marina D
Lomakin Aleksey
Vollers Sabrina S
Benedek George B
Teplow David B
References (36)
36 references, click to expand
  1. In-situ atomic force microscopy study of beta-amyloid fibrillization.
    J Mol Biol. 2000 May 19;298(5):833-40 PMID: 10801352
  2. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.
    J Neurosci. 1999 Oct 15;19(20):8876-84 PMID: 10516307
  3. Nucleated conformational conversion and the replication of conformational information by a prion determinant.
    Science. 2000 Aug 25;289(5483):1317-21 PMID: 10958771
  4. Alzheimer's amyloid fibrils: structure and assembly.
    Biochim Biophys Acta. 2000 Jul 26;1502(1):16-30 PMID: 10899428
  5. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.
    Biochim Biophys Acta. 2000 Jul 26;1502(1):172-87 PMID: 10899442
  6. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?
    Trends Neurosci. 2001 Apr;24(4):219-24 PMID: 11250006
  7. The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation?
    Biophys J. 2001 Jul;81(1):446-54 PMID: 11423427
  8. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
    Nat Neurosci. 2001 Sep;4(9):887-93 PMID: 11528419
  9. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins.
    J Biol Chem. 2001 Sep 14;276(37):35176-84 PMID: 11441003
  10. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    J Mol Biol. 2001 Oct 5;312(5):1103-19 PMID: 11580253
  11. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
    Nature. 2001 Nov 8;414(6860):212-6 PMID: 11700559
  12. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
    Nature. 2002 Apr 4;416(6880):535-9 PMID: 11932745
  13. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.
    J Biol Chem. 2002 Aug 30;277(35):32046-53 PMID: 12058030
  14. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 PMID: 6375662
  15. Amyloid plaque core protein in Alzheimer disease and Down syndrome.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 PMID: 3159021
  16. Alzheimer's disease: the amyloid cascade hypothesis.
    Science. 1992 Apr 10;256(5054):184-5 PMID: 1566067
  17. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
    Biochemistry. 1993 May 11;32(18):4693-7 PMID: 8490014
  18. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.
    Science. 1994 May 27;264(5163):1336-40 PMID: 8191290
  19. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).
    Neuron. 1994 Jul;13(1):45-53 PMID: 8043280
  20. Alzheimer's disease: a central role for amyloid.
    J Neuropathol Exp Neurol. 1994 Sep;53(5):438-47 PMID: 8083687
  21. Evidence that A beta 42 is the real culprit in Alzheimer's disease.
    Ann Neurol. 1995 Mar;37(3):287-8 PMID: 7695227
  22. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).
    J Biol Chem. 1995 Mar 31;270(13):7013-6 PMID: 7706234
  23. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.
    Exp Neurol. 1995 Nov;136(1):22-31 PMID: 7589331
  24. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.
    Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1125-9 PMID: 8577726
  25. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
    Nat Med. 1996 Aug;2(8):864-70 PMID: 8705854
  26. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.
    Chem Biol. 1997 Feb;4(2):119-25 PMID: 9190286
  27. The Alzheimer family of diseases: many etiologies, one pathogenesis?
    Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2095-7 PMID: 9122152
  28. Kinetic theory of fibrillogenesis of amyloid beta-protein.
    Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7942-7 PMID: 9223292
  29. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.
    J Biol Chem. 1997 Aug 29;272(35):22364-72 PMID: 9268388
  30. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53 PMID: 9600986
  31. An ultrastructural study of amyloid intermediates in A beta1-42 fibrillogenesis.
    Scand J Immunol. 1999 Mar;49(3):219-23 PMID: 10102637
  32. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light.
    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6020-4 PMID: 10339534
  33. Translating cell biology into therapeutic advances in Alzheimer's disease.
    Nature. 1999 Jun 24;399(6738 Suppl):A23-31 PMID: 10392577
  34. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.
    J Biol Chem. 1999 Sep 3;274(36):25945-52 PMID: 10464339
  35. Monitoring protein assembly using quasielastic light scattering spectroscopy.
    Methods Enzymol. 1999;309:429-59 PMID: 10507039
  36. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
    J Neurosci. 2000 Jun 1;20(11):4050-8 PMID: 10818140
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-01-07
Epub
2002-00-27
Pages
330-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC140968
Subset
IM
Grants
NIA NIH HHS · AG14366 · United States
NIA NIH HHS · AG18921 · United States
NIA NIH HHS · R01 AG018921 · United States
NINDS NIH HHS · NS38328 · United States
NINDS NIH HHS · R01 NS038328 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com